AMPX
Wall Street’s mood swing
Amprius Technologies is having one of those “the adults in the room are suddenly less grumpy” moments. The battery maker now sports a consensus Moderate Buy from nine analysts, with an average 12-month price target of $19.75.
That’s not exactly a moonshot, but it does suggest the Street thinks the silicon-anode story still has legs. A few firms have even pushed their targets into the $20 to $21 zone, which is analyst-speak for: “we’re not ready to bet against this one just yet.”
The catch: insiders are selling
Of course, every shiny Wall Street compliment seems to come with a little asterisk. Directors Steven Chu and Wen Hsuan Hsieh recently sold big chunks of stock, and insiders have unloaded about 4.14 million shares worth roughly $60.6 million over the past 90 days.
That doesn’t automatically mean trouble — insiders sell for all kinds of reasons, from taxes to portfolio housekeeping — but it’s the kind of thing investors notice when they’re trying to figure out whether management is quietly reaching for the exit or just cashing in some chips.
The business is still in prove-it mode
Amprius also posted a quarterly beat, with EPS of -$0.01 versus estimates for -$0.04 and revenue of $25.23 million ahead of expectations. Nice. But the company is still unprofitable, and its FY2026 guidance is still negative.
So the setup here is classic growth-stock whiplash:
- analysts like the long-term battery tech angle,
- the company is beating near-term estimates,
- but profitability is still a distant destination, not a weekend errand.
Big picture
For investors, the question isn’t whether Amprius can get people excited — it clearly can. The real test is whether the company can turn all that optimism into something sturdier than a PowerPoint deck and a price target chart.